Bayer Loses UK Protections For Billion-Dollar Blood Thinner
A London court on Friday invalidated Bayer AG's patent for its best-selling blood thinner Xarelto, agreeing with an array of generic drugmakers that the German pharmaceutical giant had given away too...To view the full article, register now.
Already a subscriber? Click here to view full article